Abstract
The results of the clinical observation of a female patient with squamous cell carcinoma of the cheek skin treated by the method of photodynamic therapy (PDT) using the photosensitizer of fotoditazin are represented. The patient had single course of PDT. Fotoditazin was injected in a dose of 0.8 mg/kg of body weight as a single intravenous infusion in 0.9% sodium chloride. The irradiation was performed once, 2.5 h after injection of the photosensitizer (power density of laser irradiation – 200-300 mW/cm 2 , light dose of a single session of 300-350 J/ cm 2 ). There were no side effects after photosensitizer injection and after irradiation. The result of the treatment was defined as partial tumor regression. For nowadays the follow-up period is 2 months. The repeated course of PDT is scheduled.
Highlights
The results of the clinical observation of a female patient with squamous cell carcinoma of the cheek skin treated by the method of photodynamic therapy
Fotoditazin was injected in a dose of 0.8 mg
The result of the treatment was defined as partial tumor regression
Summary
The results of the clinical observation of a female patient with squamous cell carcinoma of the cheek skin treated by the method of photodynamic therapy (PDT) using the photosensitizer of fotoditazin are represented. For citations: Strunkin D.N., Zharikova I.P., Kozhevnikov I.A., Zadontceva N.S. Photodynamic therapy for squamous cell skin cancer of the cheek (case report), Biomedical Photonics, 2017, T. В структуре заболеваемости злокачественными новообразованиями кожи на долю плоскоклеточного рака приходится около 20% [2]. Плоскоклеточный рак кожи в основном поражает людей пожилого и старческого возраста. Плоскоклеточный рак чаще всего представляет собой солитарную (одиночную) опухоль в виде плотного шаровидного образования в толще кожи.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
